Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 28 for “"Mood stabilizers"”.
-
The Neuroprotective Properties of Mood Stabilizers: from Gene Regulation to Ultrastructural Characterization
… The need for lifetime treatment with mood stabilizers (i.e. lithium, valproate and carbmazepine) and high relapse rates suggests that changes in gene expression may be involved in the mechanism of action of these drugs. Using differential display, we identified the 78-kilodalton …
-
Ανάπτυξη ενός μοντέλου για τη μελέτη της διπολικής διαταραχής και της δράσης των σταθεροποιητικών της διάθεσης στον επίμυ
Bipolar Disorder (BD) is a chronic recurrent mood disorder characterized by alternating episodes of depression and mania. Over the last several years there have been significant developments identifying its pathophysiology. However, the exact neurobiological substrate of the disease, as well as the …
-
ESTABLISHING THE ROLE OF MESENCEPHALIC ASTROCYTE-DERIVED NEUROTROPHIC FACTOR (MANF) AND CEREBRAL DOPAMINE NEUROTROPHIC FACTOR (CDNF) AS THERAPEUTIC TARGETS FOR BIPOLAR DISORDER
Bipolar disorder (BD) is a chronic mood disorder affecting ~1-2% of the global population, characterized by cycling moods of mania and depression. The exact pathogenesis of BD is unknown; however, it has been established that endoplasmic reticulum (ER) stress plays an important role. It is known …
-
Identification of Molecular Mechanisms That Underlie the Development and Treatment of Manic-Like Behaviors in Mice: the Importance of Cholecystokinin and Chromatin Modifications
… reversed by lithium. We also found that another mood stabilizer, valproate (VPA), has mood stabilizing effects in the ClockDelta19 mice, and that VPA causes a restoration of Cck levels in the VTA, similar to lithium. Further investigation into the regulation of the Cck gene by VPA identified a …
-
Real-World Use and Long-Term Safety of Lithium and Divalproex in Bipolar Disorder: Prescribing Trends, Treatment Discontinuation, and Risk of Chronic Kidney Disease
… one-year of initiation. Compared to groups of no mood stabilizers, lithium use (Hazard Ratio (HR) ranging from 1.08 to 1.26) was not associated with an increased CKD risk. However, when compared to divalproex, lithium (HR ranging from 2.30 to 2.61) and no mood stabilizers (HR ranging from 1.96 to …
-
Enrichment-discontinuation designs in psychiatric drug maintenance therapy
… conducted to identify all maintenance trials of mood stabilizers and antidepressants. Planned comparisons between enrichment discontinuation trials and gold standard classic RCT's were conducted. Finally, a sample of research literature was reviewed to identify the extent to which the limits of …
-
Efectividad de la ketamina en depresión bipolar: revisión sistemática de la literatura
… of bipolar disorder is pathologically elevated mood, this is often not the prevailing mood of the disease. The depressive phase of bipolar disorder or bipolar depression is more chronic, leads to further deterioration and represents an usual therapeutic challenge. At present, the pharmacological …
-
Steroid associated psychiatric burden in cancer patients
… antipsychotics, benzodiazepines, anticonvulsants/mood stabilizers, opioids) are provided for patients receiving no, less and more than 80 mg of prednisone equivalent.
-
An assessment of medication pattern changes in prescription received by youth offenders in divison of youth services facilities through telepsychiatry
… decrease in the prescription of Anti-psychotics, Mood Stabilizers and Alpha Agonists. Medication prescribed during the first visit when compared to the medication prescribed in the subsequent visits, we found out that there is a decrease in the prescription of Anxiolytics, Alpha agonists, …
-
Safety and Effectiveness of Antidepressants in Medicaid-Enrolled Pediatric Bipolar Depression
… 2003). Although medication regimens includingmood stabilizers, antidepressants, and antipsychotics for treating bipolar depression in adults is well established (Lin et al., 2006), similar treatment guidelines for bipolar depression in younger populations are unavailable. Efficacy of different …
-
Psichodelikai psichiatrijoje: efektyvumas ir rizika /
… symptoms like auditory hallucinations, excessive mood fluctuations, etc. We know that these drugs influence certain brain chemicals and alter gene expression and protein synthesis; however, these biological effects do not translate into lasting positive psychological effects since the symptoms …
-
Νευροψυχολογική και πειραματική διερεύνηση της δράσης του λιθίου επί των νοητικών λειτουργιών με έμφαση στις επιτελικές λειτουργίες
… most commonly used pharmacological treatments, mood stabilizers. This possibility is supported by extensive data on the neurotrophic and neuroprotective properties of lithium in particular, as well as more limited data in that direction on alternative mood stabilizers of the anticonvulsant …
-
Distinguishing bipolar disorder and borderline personality disorder: an exploration of clinical and neuroscience informed approaches
… are common psychiatric diagnoses. One is a mood disorder with a strong genetic basis while the other is a disorder of personality commonly related to abusive experiences in childhood. Despite contrasting aetiologies they can be difficult to differentiate because of overlapping clinical …
-
BIPOLAR DISORDER TREATMENT CHANGES AFTER NONFATAL SUICIDE ATTEMPT AND ASSOCIATION WITH SUBSEQUENT SUICIDE ATTEMPTS: AN ANALYSIS OF U.S. VETERANS
… characterize bipolar disorder antipsychotic and mood stabilizer prescribing practices before and after a first nonfatal suicide attempt and 2) evaluate if new prescriptions for mood stabilizers and antipsychotics within 14 days of a nonfatal suicide attempt are an indicator for reduced risk of …
-
Kindling, drugs and decision-making : an exploration of the effect of anticonvulsant drugs and provoked seizures on a rat Gambling Task
… used in the treatment of epilepsy, but also as mood stabilizers and prophylaxis for the management of bipolar disorder. Unfortunately, little is still known about the precise mechanisms of action underlying their efficacy, and the specific behavioural aspect targeted by these drugs. Patients …
-
The discovery of novel GSK3 substrates and their role in the brain
… yet clear. A major target of lithium (and other mood stabilizers) is Glycogen Synthase Kinase-3 (GSK-3), a Ser/Thr protein kinase that is dysregulated in BD. Pathogenic targets of GSK3 could become novel therapeutic targets for improved treatment of BD, although these are not yet known. …
-
Analysis of miRNome expression profile in hippocampus of rats treated with antidepressants
… for mental disorders pathophysiology, including mood disorders, and in psychotropic drugs action, such as mood stabilizers and antidepressants (ADs). Aim of the studies presented was to analyze whether modulation of hippocampal miRNome could be part of the mode of action of different ADs, …
-
Lipidomic analysis of medication classes in individuals with psychosis spectrum disorders
… When lithium is grouped together with the other mood stabilizers as a single category, the mood stabilizer group shows few significant alterations, indicating strong effects of individual drugs but no common trend. Conclusion: The findings of this thesis highlight the significant impact of …
-
Padronização de testes para avaliação do estado de mania e potencial anti-maníaco de um agonista do receptor NOP
Bipolar disorder is characterized by mood impairment, alternating between mania/hypomania and depression, and its exact pathophysiology is already unknown. The treatment of bipolar disorder is based on prevention of the manic and depressive episodes using mood stabilizers. Nociceptin/orfanin FQ …
Page 1 of 2